Immunohistochemistry

Indirect immunohistochemistry (IHC) and immunofluorescence (IF) detection methods for cells and tissue samples

Immunohistochemistry (IHC) and Immunofluorescence (IF) Detection Methods

Immunohistochemistry (IHC) is a biochemical method that uses antibodies that bind to specific antigens in a section of tissue. Similarly, immunocytochemistry (ICC) is suitable for identifying antigens in individual cell layers. IHC is commonly used to visualize proteins, carbohydrates, and lipids of interest in both healthy and diseased tissues, such as those found in cancerous tumors. Specific molecular markers are characteristic of cellular events such as proliferation or cell death (apoptosis). IHC is also widely used in basic research to understand the distribution and localization of biomarkers and differentially expressed proteins in different parts of biological tissue.

IHC Tissue Preparation, Antigen Retrieval and Pretreatment

Typically, tissues are fixed, embedded in paraffin, and sectioned for IHC analysis using a microtome. A significant step following the initial tissue preparation is the need for antigen retrieval. It is needed to break the protein cross-links formed during fixation and uncover hidden antigenic sites. Antigen retrieval and pretreatment conditions must be determined empirically, as the accessibility of the antigen epitope may vary significantly depending on numerous biological factors. For example, some antigens may require a more aggressive pretreatment in order to “unmask” their antibody-binding epitopes, while pretreatment may not be required at all for some antigens. Two common antigen retrieval pretreatment methods include Heat-Induced Epitope Retrieval (HIER) where a heat source is used in conjunction with buffers and enzymes (proteinase K). The second method, Proteolytic-Induced Epitope Retrieval (PIER) is another antigen retrieval method where various proteases may be used, such as proteinase k, trypsin, chymotrypsin or pepsin.

IHC Staining and Detection

Following tissue preparation and antigen retrieval pretreatment, visualizing the antibody-antigen interaction can be accomplished in a number of ways. One common method uses a primary antibody that is conjugated to an enzyme, such as horseradish peroxidase or alkaline phosphatase, that catalyzes a color-producing reaction. Alternatively, the immunofluorescence (IF) method uses an antibody that is tagged to a fluorophore, such as fluorescein, rhodamine, or Alexa Fluor. Another option is to use an unlabeled primary antibody, with indirect antigen detection by a labeled secondary antibody or more complex detection systems. In this case, the optimal titer of both the primary and secondary antibody should be determined for each assay.


Related Technical Articles

  • In the midst of beeping lab timers, presentations and grant deadlines, it is easy to take for granted the quality of lab reagents.
  • Immunohistochemistry (IHC) is used to characterize intracellular proteins or various cell surfaces in all tissues. Individual markers or more often panels of various marker proteins can be used to characterize various tumor subtypes, confirm tissue of origin, distinguish metastatic from primary tumor and provide additional information which may be important for prognosis, predicting response to therapy or evaluating residual tumour post-treatment.
  • Detailed information about antibody validation including, information on antibody and target, species validation, lot validation, application validation, storage and handling, citations and quality control.
  • Antibodies will combine with specific antigens to generate an exclusive antibody-antigen complex. Learn about the nature of this bond, and the use of this robust and specific binding as a molecular tag for research.
  • The inherent immune ability of an animal can be leveraged to generate antibodies that bind to specific molecules.
  • See All

Related Protocols




Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.